Clinical Trials on Glabellar Crease in United Kingdom

Total 7463 results

Northwestern University
National Cancer Institute (NCI)

Withdrawn

Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the Leptomeninges

United States
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health (NIH)

Completed

Genetic Counseling for Breast Cancer Survivors (GC for BC)

Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Breast Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers

Breast Cancer | Fatigue | Cognitive/Functional Effects | Long-term Effects Secondary to Cancer Therapy in Adults

United States
Duke University

Not yet recruiting

Planning Grant for TOPS for Breast Cancer Survivors

Breast Cancer | Weight Loss

United States
U-Systems, Inc.

Completed

A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts. (somo•InSIGHT)

Breast Cancer

United States
InventisBio Co., Ltd

Completed

A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer

Breast Cancer

United States, China
Northwestern University
National Cancer Institute (NCI); Pfizer

Terminated

Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the Brain

United States
National Cancer Institute (NCI)

Completed

A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children

Breast Cancer

United States
Zeno Alpha Inc.

Completed

A Study of ZN-c5 in Participants With Breast Cancer

Breast Cancer

United States, Australia, Bosnia and Herzegovina
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer (MONALEESA-2)

Advanced, Metastatic Breast Cancer

United States, Italy, Spain, Hungary, Taiwan, Belgium, Germany, Netherlands, Austria, Czechia, Australia, Canada, Israel, Russian Federation, United Kingdom, Korea, Republic of, Thailand, Lebanon, Denmark, France, Argentina, Sweden, Finlan... and more
Sysmex America, Inc.

Terminated

Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy

Breast Neoplasms | Breast Diseases

United States
University of California, San Francisco
Central South University

Completed

SCOPE-Chinese Women Study (SCOPE)

Obesity, Abdominal | Cancer, Breast

United States, China
University of California, Los Angeles
W.K. Kellogg Foundation; Center for HIV Identification, Prevention, and Treatment...

Completed

Home Visiting for Low Income, Pregnant Women

Pregnant Women | Breast Feeding | Newborns | Nutrition During Pregnancy

United States
California Pacific Medical Center Research Institute
National Center for Complementary and Integrative Health (NCCIH)

Completed

Distance Healing in Wound Healing

Breast Reconstruction Surgery

United States
Rutgers, The State University of New Jersey

Suspended

Pilot Trial of Preop Partial Radiation in Breast Cancer Patients

Breast Carcinoma | Early-stage Breast Cancer | DCIS

United States
M.D. Anderson Cancer Center

Completed

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

Ductal Carcinoma In Situ

United States
Northwestern University
Robert H. Lurie Cancer Center

Terminated

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

Metastatic Breast Cancer | Metastatic Non Small Cell Lung Cancer

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer

Breast Cancer

United States, Poland, Ukraine, United Kingdom, Spain, Israel, Bulgaria, Romania, Serbia, South Africa, Russian Federation, Hungary, Lithuania, Netherlands, Latvia, Portugal, Estonia, France
The University of Texas Health Science Center,...

Completed

Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention

Increase HPV Vaccination Uptake | Delay Sexual Debut

United States
Bristol-Myers Squibb
US Oncology Research

Completed

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic

Metastatic Breast Cancer

United States
Dana-Farber Cancer Institute
Gateway for Cancer Research; Susan G. Komen Breast Cancer Foundation

Active, not recruiting

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute
Pfizer

Active, not recruiting

Palbociclib After CDK and Endocrine Therapy (PACE)

Metastatic Breast Cancer

United States
Orinove, Inc.

Completed

ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer

Metastatic Breast Cancer | Advanced Solid Tumor

United States
OBI Pharma, Inc

Completed

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Metastatic Breast Cancer

United States, Taiwan, Korea, Republic of, China, India
Aston Sci. Inc.

Terminated

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer (Cornerstone001)

Breast Cancer

United States, Taiwan
GlaxoSmithKline

Completed

Rollover Study Of Lapatinib In Cancer Patients

Neoplasms, Breast

United States, Israel, Canada
Koya Medical, Inc.

Completed

A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema (NILE)

Lymphedema | Lymphedema of Upper Arm | Lymphedema, Breast Cancer

United States
Syndax Pharmaceuticals

Completed

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer (ENCORE301)

Breast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-Positive

United States, Czechia, Canada, Hungary, Russian Federation
Duke University
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Columbia... and other collaborators

Completed

Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer

Breast Neoplasms | Early Detection of Cancer

United States
Daiichi Sankyo
AstraZeneca

Active, not recruiting

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

Breast Cancer | Advanced Solid Tumor

Spain, United States, Canada, France
American College of Radiology
GE Healthcare; Breast Cancer Research Foundation

Recruiting

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts (CMIST)

Breast Cancer

United States, Canada
AstraZeneca
Daiichi Sankyo

Active, not recruiting

Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer (DB-06)

Advanced or Metastatic Breast Cancer

United States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Taiwan, Germany, Brazil, Mexico, Poland, United Kingdom, China, Israel, Austria, Australia, Japan, Saudi Arabia, Netherlands, India, Argentina, Sweden, Singapore, Por... and more
Puma Biotechnology, Inc.

Completed

A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting (NALA)

HER2+ Metastatic Breast Cancer (MBC)

United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
Fox Chase Cancer Center
Pfizer; University of Alabama, Tuscaloosa; Institut de Recherche en Sciences... and other collaborators

Recruiting

African Cancer Genome: GMD

Breast Cancer | Prostate Cancer

United States
Ohio State University Comprehensive Cancer Center
National Center for Complementary and Integrative Health (NCCIH)

Completed

Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients

Breast Cancer | Prostate Cancer

United States
University of Arkansas
U of A

Completed

A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework

Breast Cancer | Prostate Cancer

United States
Astellas Pharma Inc

Terminated

A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery

Melanoma | Breast Cancer | Sentinel Lymph Node Biopsy

United States
OHSU Knight Cancer Institute

Completed

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

Breast Cancer | Menopause | Vulvodynia | Dyspareunia

United States
University of Wisconsin, Milwaukee

Completed

Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy

Breast Neoplasms

United States
UNC Lineberger Comprehensive Cancer Center

Active, not recruiting

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Breast Cancer

United States
Seagen Inc.

Completed

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Triple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast Neoplasms

United States
Endeavor Health
Patient-Centered Outcomes Research Institute; Northwestern University; University... and other collaborators

Recruiting

Furthering Equity Through Infant Feeding EDucation and Support (FEEDS)

Breastfeeding

United States
George Washington University

Completed

Intergenerational Transmission of Low-calorie Sweeteners Via Breast Milk

Breastfeeding

United States
Gilead Sciences
Alliance Foundation Trials, LLC.; NSABP Foundation Inc; GBG Forschungs GmbH

Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) (ASCENT-05)

Triple Negative Breast Cancer

United States, Australia, Spain, United Kingdom, France, Germany, Belgium, Ireland, Italy, South Korea, Brazil
Enzon Pharmaceuticals, Inc.

Terminated

A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer (PEG-SN38)

Metastatic Breast Cancer

United States
Optimal Health Research

Completed

Diet Effect on Cancer Treatment Outcome

Cancer Breast | Cancer Prostate

United States, India

Clinical Trials on Glabellar Crease in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations